Citius Pharmaceuticals, Inc. (CTXR)
0.5817
-0.02
(-3.37%)
USD |
NASDAQ |
Sep 04, 16:00
0.5817
0.00 (0.00%)
After-Hours: 18:02
Citius Pharmaceuticals Price to Book Value : 0.2397 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 0.2481 |
| September 02, 2026 | 0.2388 |
| September 01, 2026 | 0.2345 |
| August 31, 2026 | 0.2391 |
| August 28, 2026 | 0.2481 |
| August 27, 2026 | 0.2592 |
| August 26, 2026 | 0.2378 |
| August 25, 2026 | 0.2488 |
| August 24, 2026 | 0.2371 |
| August 21, 2026 | 0.2474 |
| August 20, 2026 | 0.2472 |
| August 19, 2026 | 0.2627 |
| August 18, 2026 | 0.2357 |
| August 17, 2026 | 0.2316 |
| August 14, 2026 | 0.3114 |
| August 13, 2026 | 0.3023 |
| August 12, 2026 | 0.3153 |
| August 11, 2026 | 0.2967 |
| August 10, 2026 | 0.279 |
| August 07, 2026 | 0.2812 |
| August 06, 2026 | 0.2646 |
| August 05, 2026 | 0.3218 |
| August 04, 2026 | 0.2565 |
| August 03, 2026 | 0.2456 |
| July 31, 2026 | 0.2349 |
| Date | Value |
|---|---|
| July 30, 2026 | 0.2605 |
| July 29, 2026 | 0.2345 |
| July 28, 2026 | 0.2052 |
| July 27, 2026 | 0.213 |
| July 24, 2026 | 0.2144 |
| July 23, 2026 | 0.219 |
| July 22, 2026 | 0.2317 |
| July 21, 2026 | 0.2248 |
| July 20, 2026 | 0.1981 |
| July 17, 2026 | 0.2043 |
| July 16, 2026 | 0.2104 |
| July 15, 2026 | 0.2189 |
| July 14, 2026 | 0.2192 |
| July 13, 2026 | 0.2225 |
| July 10, 2026 | 0.2401 |
| July 09, 2026 | 0.2313 |
| July 08, 2026 | 0.2297 |
| July 07, 2026 | 0.2405 |
| July 06, 2026 | 0.2504 |
| July 02, 2026 | 0.2368 |
| July 01, 2026 | 0.2509 |
| June 30, 2026 | 0.2491 |
| June 29, 2026 | 0.2104 |
| June 26, 2026 | 0.1963 |
| June 25, 2026 | 0.1982 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Citius Oncology, Inc. | 2.215 |
| ANI Pharmaceuticals, Inc. | 2.739 |
| Corcept Therapeutics, Inc. | 17.09 |
| Veru, Inc. | 1.592 |
| Johnson & Johnson | 7.801 |
Price to Book Value Related Metrics
| PS Ratio | 1.803 |
| Price | 0.5817 |
| Earnings Yield | -362.8% |
| Market Cap | 15.97M |